Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC) — Maria Vassilakopoulou (2011) | RDL Network
Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC)
Article 2011 en
Authors
MV
Maria Vassilakopoulou
TR
Thibault De La Motte Rouge
PC
Pierre Colin
Abstract
1 min read
Adjuvant postoperative chemotherapy did not offer any significant benefit to overall survival in our population. Additional data were necessary, and studies enrolling patients at high risk in clinical trials investigating neoadjuvant chemotherapy in conjunction with chemotherapy should have been highly encouraged.
Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Oscar Tendero, Robert Díaz Beveridge, Virginia Ferraresi, Iwona Ługowska, Gabriele Infante, Luca Braglia, Domenico Franco Merlo, Valeria Fontana, Emanuela Marchesi, Davide María Donati, Elena Palassini, Giuseppe Bianchi, Andrea Marrari, Carlo Morosi, Silvia Stacchiotti, Sílvia Bagué, Jean Michel Coindre, Angelo Paolo Dei Tos, Piero Picci, Paolo Bruzzi, Rosalba Miceli, Paolo G. Casali, Alessandro Gronchi
Christian U. Blank, Judith M. Versluis, Elisa A. Rozeman, Alexander M. Menzies, Irene L. M. Reijers, Oscar Krijgsman, Esmée P. Hoefsmit, Bart A. van de Wiel, Karolina Sikorska, Carolien Bierman, Petros Dimitriadis, Maria Gonzalez, Annegien Broeks, Ron Kerkhoven, Andrew J. Spillane, John B.A.G. Haanen, Winan J. van Houdt, Robyn P.M. Saw, Hanna Eriksson, Alexander C.J. van Akkooi, ,
Discussion(0)
No comments yet. Be the first to comment.